4.4 Letter

The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure

Journal

HAEMATOLOGICA
Volume 101, Issue 6, Pages E224-E227

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2015.140962

Keywords

MDS; hypomethylating agent; prognostic models

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available